North Carolina Baptist Hospital
Winston-Salem, North Carolina, 27612, United States
NCT Number: NCT03057704
Intravenous lidocaine is commonly given through an intravenous (IV) line prior to injection of propofol to reduce the amount of pain during propofol injection. The investigators want to study if giving the lidocaine through the IV while the forearm on the same limb has a tourniquet applied to it to prevent "washing out" of the lidocaine prior to propofol injection helps reduce propofol injection pain.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Phase 4
Winston-Salem, North Carolina, 27612, United States
The investigators expect that tourniquet lidocaine is superior to straight non-tourniquet lidocaine in reducing propofol injection pain. The investigators also wanted to determine the association of tourniquet duration on reduction of pain with propofol administration. Small studies indicate that 60 seconds of tourniquet lidocaine is superior to 30 seconds or less of tourniquet duration or mixed lidocaine/propofol for injection. The investigators suspect many clinicians do not use the 60-second tourniquet technique due to the extra time involved but hypothesize that a more practical application by applying the tourniquet as soon as the patient is positioned on the operating table will not only be more widely adopted by clinicians as it does not cause delay but also provide the necessary amount of time for benefit from the tourniquet. The investigators also wanted to record the time from tourniquet application to start of propofol administration, which the investigators predict would be at least 60 seconds to see if there is a correlation between duration of venous stasis of IV lidocaine and pain benefit.
Methods and Measures
Design This was conducted as a randomized controlled trial of two methods of administering lidocaine prior to propofol injection.
Setting The study setting was located within North Carolina Baptist Health, an academic medical center, in the Endoscopy Suite or Outpatient Surgery Center where subjects were scheduled to receive propofol as part of their sedation or anesthetic.
Sample Size The investigators estimated that 25 subjects in each of the two groups was required to test the hypothesis based on prior studies.
Interventions and Interactions
The investigators used two groups:
For both groups, no premedication was given, which is the normal practice for these procedures. Study procedures involved placing a 20 gauge intravenous (IV) catheter in a vein distal to the mid forearm. Venous occlusion was achieved by either a latex free tourniquet or McKesson Quick Release tourniquet applied to the forearm 10cm distal to the elbow joint. Tourniquet pressure was somewhat variable but sufficient to cause venous stasis as confirmed by no flow of hanging IV fluid. Injections were delivered at roughly 1 ml/sec.
Schedule of events in the study (all performed by 1 of the 2 investigators:
-Accompany subject to the operating or procedure room, perform protocol from the group to which the subjects were assigned, while noting outcome measures such as self-described discomfort and observer graded discomfort
-Revisit subject in recovery 30 minutes after their procedure to determine post-procedure recall of discomfort
Analytical Plan The investigators will analyze results initially using descriptive statistics. Comparison between groups was done using chi square tests for proportions, and t-tests or ANOVA procedures for continuous variables. Regression analysis was performed to identify independent outcome predictors. Other inferential statistical analysis was conducted as appropriate.
Informed Consent One of the two investigators obtained signed informed consent from each subject. This was performed in the holding room prior to the procedure since most subjects had their pre-procedure examination performed in the holding room and were not seen prior to the day of their procedure.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The investigator administers IV lidocaine and flushes it into the subject prior to administering propofol.
Other names: Xylocaine
Intravenous lidocaine: tourniquet
Other names: Xylocaine, Tourniquet
Time frame: During injection at beginning of study; lasts 10 seconds one time only
Patient's verbal rating of pain during injection (see link to study protocol)
We used a Verbal Rating Scale from the patient that self-described discomfort level during injection using question:
How would you rate your pain using None, Mild, Moderate, Severe and record it on this 4-point scale:
Time frame: This occurs 30 minutes after the subject's procedure is finished in the recovery room; lasts 30 seconds one time only
Investigator asks patient if they recall discomfort during injection after the procedure.
Patient's verbal rating and recall of pain during injection.
We used a Verbal Rating Scale from the patient that self-described discomfort level during injection using question:
How would you rate your pain using None, Mild, Moderate, Severe and record it on this 4-point scale:
Time frame: During injection at beginning of study period; lasts 10 seconds one time only
Investigator rates patient's nonverbal display of discomfort.
Investigator Assessments:
Induction Discomfort Scale (during injection and within 5 seconds after injection)
Wake Forest University Health Sciences
Other
Comparison of Two Techniques of Administering IV Lidocaine in Reducing Propofol Injection Pain
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03145519
Administration, Intravenous, Injections, Intravenous
Tartu, Estonia
View Trial DetailsNCT07025161
Neurologic Manifestations, Pain
Orlando, Florida, United States
View Trial DetailsNCT04949659
Appendicitis, Appendicitis Acute
Zurich, Canton of Zurich, Switzerland
View Trial DetailsNCT05283980
Acute Pain, Behavior
Boston, Massachusetts, United States
View Trial Details